S&P 및 Nasdaq 내재가치 문의하기

Ayala Pharmaceuticals, Inc. ADXS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Ayala Pharmaceuticals, Inc. (ADXS), 포함 33 건 매수8 건 매도. 내부자 매수 총액은 $283.03K 내부자 매도 총액은 $4.88M.

최근 활동이 있는 주요 내부자에는 Israel Biotech Fund I, L.p., Amoon Growth Fund Limited Partnership, Martell Bridget A. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — ADXS

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-03-01 Israel Biotech Fund I, L.p. 10 Percent Owner 옵션 행사 (매도) 3,750,000 $0.40 $1.5M 4,087,500
2024-02-07 Israel Biotech Fund I, L.p. 10 Percent Owner 옵션 행사 (매도) 8,437,500 $0.40 $3.38M 7,837,500
2023-11-17 Israel Biotech Fund I, L.p. 10 Percent Owner 정보 매수 - $0.40 - 6,034,308
2023-10-18 Amoon Growth Fund Limited Partnership 10 Percent Owner 기타 (매도) - - - 560,602
2023-10-18 Israel Biotech Fund I, L.p. 10 Percent Owner 정보 매수 658,858 - - 1,094,091
2023-10-18 Martell Bridget A Officer 알 수 없음 - - - -
2023-10-18 Orbach Pini Officer 알 수 없음 - - - -
2023-10-18 Golan Roy Officer 알 수 없음 - - - -
2023-10-18 Cabilly Yuval Director 알 수 없음 - - - 621,253
2023-09-01 Israel Biotech Fund I, L.p. 10 Percent Owner 정보 매수 - - - 434,783
2023-09-01 Israel Biotech Fund I, L.p. 10 Percent Owner 정보 매수 - - - 434,783
2023-01-19 Israel Biotech Fund I, L.p. 10 Percent Owner 알 수 없음 - - - 621,253
2023-01-19 Goldberg Murray A Director 알 수 없음 - - - -
2023-01-19 Goldberg Murray A Director RSU 부여 1,171 - - 1,171
2023-01-19 Sidransky David Director RSU 부여 46 - - 46
2023-01-19 Spiegel Robert J. Director 알 수 없음 - - - -
2023-01-19 Spiegel Robert J. Director RSU 부여 1,171 - - 1,171
2023-01-19 Bisker-leib Vered Director 알 수 없음 - - - -
2023-01-19 Bisker-leib Vered Director RSU 부여 1,171 - - 1,171
2023-01-19 Israel Biotech Fund I, L.p. 10 Percent Owner 알 수 없음 - - - 621,253
2023-01-19 Amoon Growth Fund Limited Partnership Director 처분 - - - 560,602
2021-02-11 Gitelman Igor Chief Accounting Officer 처분 50,000 - - -
2020-05-04 Berman Richard J Director RSU 부여 13,000 $0.66 $8.58K 13,000
2020-05-04 Sidransky David Director RSU 부여 13,000 $0.66 $8.58K 13,000
2020-05-04 Appel Roni Director RSU 부여 13,000 $0.66 $8.58K 13,000
2020-05-04 Patton James P Director RSU 부여 13,000 $0.66 $8.58K 13,000
2020-05-04 Henderson Molly Executive Vice President & CFO RSU 부여 50,000 $0.66 $33K 50,000
2020-05-04 Khleif Samir N Director RSU 부여 13,000 $0.66 $8.58K 13,000
2020-05-04 Berlin Kenneth A President and CEO RSU 부여 50,000 $0.66 $33K 50,000
2020-05-04 Gutierrez Andres Executive Vice President & CMO RSU 부여 50,000 $0.66 $33K 50,000
2020-03-13 Appel Roni Director 정보 매도 2,401 $0.55 $1.32K 10,476
2020-03-12 Appel Roni Director 정보 매도 200 $0.58 $116.00 12,877
2020-03-11 Appel Roni Director 정보 매도 399 $0.67 $267.33 13,077
2019-10-24 Berman Richard J Director RSU 부여 10,000 $0.31 $3.1K 10,000
2019-10-24 Sidransky David Director RSU 부여 10,000 $0.31 $3.1K 10,000
2019-10-24 Appel Roni Director RSU 부여 10,000 $0.31 $3.1K 10,000
2019-10-24 Patton James P Director RSU 부여 10,000 $0.31 $3.1K 10,000
2019-10-24 Henderson Molly Executive Vice President & CFO RSU 부여 25,000 $0.31 $7.75K 25,000
2019-10-24 Khleif Samir N Director RSU 부여 10,000 $0.31 $3.1K 10,000
2019-10-24 Berlin Kenneth A President & CEO RSU 부여 50,000 $0.31 $15.5K 50,000
2019-10-24 Gutierrez Andres Exec VP, Chief Medical Officer RSU 부여 25,000 $0.31 $7.75K 25,000
2019-04-11 Henderson Molly Executive Vice President & CFO RSU 부여 2,500 $3.68 $9.2K 5,833
2019-04-11 Gutierrez Andres Executive Vice President & CMO RSU 부여 3,750 $3.71 $13.93K 3,750
2019-04-10 Appel Roni Director 정보 매수 3,000 $3.80 $11.39K 13,476
2019-04-09 Henderson Molly Executive Vice President & CFO RSU 부여 100 $3.85 $385.00 100
2019-04-08 Berlin Kenneth A President & CEO RSU 부여 800 $3.78 $3.02K 800
2018-11-05 Berman Richard J Director RSU 부여 25,000 $0.54 $13.5K 25,000
2018-11-05 Sidransky David Director RSU 부여 30,000 $0.54 $16.2K 30,000
2018-11-05 Appel Roni Director RSU 부여 25,000 $0.54 $13.5K 25,000
2018-11-05 Patton James P Director RSU 부여 25,000 $0.54 $13.5K 25,000
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기